The effect of heterologous antilymphocytic serum on the oncogenic activity of polyoma virus.
D000818:Animals; D001932:Brain Neoplasms / Q000276:immunology; D006086:Graft vs Host Disease / Q000276:immunology; D006385:Hemagglutination Inhibition Tests; D006391:Hemangioma / Q000150:complications; D007106:Immune Sera; D007166:Immunosuppressive Agents / Q000494:pharmacology; D007680:Kidney Neoplasms / Q000276:immunology; D007964:Leukocytosis / Q000150:complications; D008214:Lymphocytes / Q000276:immunology*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology*; D011120:Polyomavirus; D011817:Rabbits; D051381:Rats; D012513:Sarcoma, Experimental / Q000276:immunology; D013934:Thymectomy; D014181:Transplantation Immunology
D007106:Immune Sera; D007166:Immunosuppressive Agents